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Purpose: The VerifyNow P2Y12 assay is a rapid point-of-care which assesses clopidogrel-induced inhibition. This assay uses PGE1 in combination 
to ADP as agonists, making it specific to assess P2Y12 receptor blockade. Controversies exist on the correlation between light transmittance 
aggregometry (LTA) using ADP stimuli, which is considered the gold standard to test for clopidogrel-induced antiplatelet effects, with the VerifyNow 
P2Y12 assay. In addition, it is unknown if adding PGE1 to ADP in the LTA assay impacts this correlation.
Methods: Platelet function was assessed in patients during their maintenance phase of clopidogrel therapy (75mg/day). The VerifyNow P2Y12 
assay reports results as P2Y12 reaction units (PRU) as well as percentage inhibition (%IPA). LTA was performed with 5 and 20 μmol/L ADP stimuli 
in the presence and absence of 5nM PGE1. Aggregation was measured at peak (Aggmax). Correlation analyses were performed between results 
obtained with the VerifyNow P2Y12 assay and LTA parameters.
Results: Platelet function testing were performed in 120 blood samples. Using the VerifyNow P2Y12 assay, PRU and %IPA values were 171±85 and 
41±26, respectively. LTA values and their correlation (r-value) with the VerifyNow P2Y12 parameters are summarized in the Table. 
Correlation between LTA and VerifyNow P2Y12
Platelet Aggregation Value (%) Correlation with PRU Correlation with %IPA
Agg-max5 μmol/L ADP 34±15 0.70 p<0.0001 -0.64 p<0.0001
Agg-max20 μmol/L ADP 47±17 0.74 p<0.0001 -0.75 p<0.0001
Agg-max5 μmol/L ADP + PGE1 23±16 0.80 p<0.0001 -0.76 p<0.0001
Agg-max20 μmol/L ADP + PGE1 37±20 0.83 p<0.0001 -0.83 p<0.0001
Conclusion: There is a strong correlation between VerifyNow P2Y12 and LTA parameters, which is best with aggregation values obtained following 
addition of PGE1 to ADP stimuli.
